_id
69148b2accc777a4e85d9970
Ticker
PCVX
Name
Vaxcyte Inc
Exchange
NASDAQ
Address
825 Industrial Road, San Carlos, CA, United States, 94070
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://vaxcyte.com
Description
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; and VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Last Close
44.59
Volume
1825900
Current Price
44.5
Change
-0.20183897734918904
Last Updated
2025-12-03T11:55:00.649Z
Image
data:image/webp;base64,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
Ipo Date
2020-06-12T00:00:00.000Z
Market Cap
5851510272
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.7875555555555556
Sentiment Sources
9
Rating
4.9
Target Price
92
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
242380000
Operating Income
-242380000
Interest Expense
-
Pretax Income
-212830000
Net Income
-212830000
Eps
-1.5626743810390906
Dividends Per Share
-
Shares Outstanding
130906263
Income Tax Expense
-
EBITDA
-209766000
Operating Margin
-
Total Other Income Expense Net
29550000
Cash
281080000
Short Term Investments
1430240000
Receivables
400000
Inventories
-
Total Current Assets
1767167000
Property Plant Equipment
337001000
Total Assets
3171600000
Payables
48962000
Short Term Debt
5771000
Long Term Debt
-
Total Liabilities
278718000
Equity
2892882000
Depreciation
5197000
Change In Working Capital
14198000
Cash From Operations
-143305000
Capital Expenditures
12046000
Cash From Investing
121170000
Cash From Financing
-3671000
Net Change In Cash
-25515000
PE
-
PB
2.0950463931816095
ROE
-7.357023203850001
ROA
-6.710493126497667
FCF
-155351000
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
242380000
Quarters > 0 > income Statement > operating Income
-242380000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-212830000
Quarters > 0 > income Statement > net Income
-212830000
Quarters > 0 > income Statement > eps
-1.5626743810390906
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
136196000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-209766000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
29550000
Quarters > 0 > balance Sheet > cash
281080000
Quarters > 0 > balance Sheet > short Term Investments
1430240000
Quarters > 0 > balance Sheet > receivables
400000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1767167000
Quarters > 0 > balance Sheet > property Plant Equipment
337001000
Quarters > 0 > balance Sheet > total Assets
3171600000
Quarters > 0 > balance Sheet > payables
48962000
Quarters > 0 > balance Sheet > short Term Debt
5771000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
278718000
Quarters > 0 > balance Sheet > equity
2892882000
Quarters > 0 > cash Flow > net Income
-212830000
Quarters > 0 > cash Flow > depreciation
5197000
Quarters > 0 > cash Flow > change In Working Capital
14198000
Quarters > 0 > cash Flow > cash From Operations
-143305000
Quarters > 0 > cash Flow > capital Expenditures
12046000
Quarters > 0 > cash Flow > cash From Investing
121170000
Quarters > 0 > cash Flow > cash From Financing
-3671000
Quarters > 0 > cash Flow > net Change In Cash
-25515000
Quarters > 0 > ratios > PE
-1.5626743810390906
Quarters > 0 > ratios > PB
2.0950463931816095
Quarters > 0 > ratios > ROE
-7.357023203850001
Quarters > 0 > ratios > ROA
-6.710493126497667
Quarters > 0 > ratios > FCF
-155351000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
4989000
Quarters > 1 > income Statement > gross Profit
-4989000
Quarters > 1 > income Statement > operating Expenses
221230000
Quarters > 1 > income Statement > operating Income
-226219000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-166573000
Quarters > 1 > income Statement > net Income
-166573000
Quarters > 1 > income Statement > eps
-1.2244976331093609
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
136033746
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-161584000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
59646000
Quarters > 1 > balance Sheet > cash
306744000
Quarters > 1 > balance Sheet > short Term Investments
1354683000
Quarters > 1 > balance Sheet > receivables
100000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1715775000
Quarters > 1 > balance Sheet > property Plant Equipment
327915000
Quarters > 1 > balance Sheet > total Assets
3305363000
Quarters > 1 > balance Sheet > payables
31414000
Quarters > 1 > balance Sheet > short Term Debt
6302000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
234029000
Quarters > 1 > balance Sheet > equity
3071334000
Quarters > 1 > cash Flow > net Income
-166573000
Quarters > 1 > cash Flow > depreciation
4989000
Quarters > 1 > cash Flow > change In Working Capital
33691000
Quarters > 1 > cash Flow > cash From Operations
-121166000
Quarters > 1 > cash Flow > capital Expenditures
19516000
Quarters > 1 > cash Flow > cash From Investing
77742000
Quarters > 1 > cash Flow > cash From Financing
2518000
Quarters > 1 > cash Flow > net Change In Cash
-40106000
Quarters > 1 > ratios > PE
-1.2244976331093609
Quarters > 1 > ratios > PB
1.9709682167423017
Quarters > 1 > ratios > ROE
-5.4234739692915195
Quarters > 1 > ratios > ROA
-5.0394767533853315
Quarters > 1 > ratios > FCF
-140682000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
180793000
Quarters > 2 > income Statement > operating Income
-180793000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-140718000
Quarters > 2 > income Statement > net Income
-140718000
Quarters > 2 > income Statement > eps
-1.03704740918705
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
135691000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-175919000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
40075000
Quarters > 2 > balance Sheet > cash
346850000
Quarters > 2 > balance Sheet > short Term Investments
1324881000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1716563000
Quarters > 2 > balance Sheet > property Plant Equipment
304914000
Quarters > 2 > balance Sheet > total Assets
3378103000
Quarters > 2 > balance Sheet > payables
20514000
Quarters > 2 > balance Sheet > short Term Debt
6128000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
178077000
Quarters > 2 > balance Sheet > equity
3200026000
Quarters > 2 > cash Flow > net Income
-140718000
Quarters > 2 > cash Flow > depreciation
4874000
Quarters > 2 > cash Flow > change In Working Capital
-49515000
Quarters > 2 > cash Flow > cash From Operations
-166274000
Quarters > 2 > cash Flow > capital Expenditures
26751000
Quarters > 2 > cash Flow > cash From Investing
123317000
Quarters > 2 > cash Flow > cash From Financing
759000
Quarters > 2 > cash Flow > net Change In Cash
-41026000
Quarters > 2 > ratios > PE
-1.03704740918705
Quarters > 2 > ratios > PB
1.8869376373816962
Quarters > 2 > ratios > ROE
-4.3974017711106095
Quarters > 2 > ratios > ROA
-4.165592345763288
Quarters > 2 > ratios > FCF
-193025000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
162169000
Quarters > 3 > income Statement > operating Income
-162169000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-137080000
Quarters > 3 > income Statement > net Income
-137080000
Quarters > 3 > income Statement > eps
-1.1158761515531737
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
122845174
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-52577000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
25089000
Quarters > 3 > balance Sheet > cash
387878000
Quarters > 3 > balance Sheet > short Term Investments
1359330000
Quarters > 3 > balance Sheet > receivables
20662000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1787985000
Quarters > 3 > balance Sheet > property Plant Equipment
332624000
Quarters > 3 > balance Sheet > total Assets
3511318000
Quarters > 3 > balance Sheet > payables
48452000
Quarters > 3 > balance Sheet > short Term Debt
5891000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
205499000
Quarters > 3 > balance Sheet > equity
3305819000
Quarters > 3 > cash Flow > net Income
-137080000
Quarters > 3 > cash Flow > depreciation
4785000
Quarters > 3 > cash Flow > change In Working Capital
-2485000
Quarters > 3 > cash Flow > cash From Operations
-111401000
Quarters > 3 > cash Flow > capital Expenditures
30027000
Quarters > 3 > cash Flow > cash From Investing
-557168000
Quarters > 3 > cash Flow > cash From Financing
4907000
Quarters > 3 > cash Flow > net Change In Cash
-662312000
Quarters > 3 > ratios > PE
-1.1158761515531737
Quarters > 3 > ratios > PB
1.6536326529068892
Quarters > 3 > ratios > ROE
-4.1466275074346175
Quarters > 3 > ratios > ROA
-3.903947178808641
Quarters > 3 > ratios > FCF
-141428000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
43
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
15845000
Annuals > 0 > income Statement > gross Profit
-15845000
Annuals > 0 > income Statement > operating Expenses
569546000
Annuals > 0 > income Statement > operating Income
-569546000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-463927000
Annuals > 0 > income Statement > net Income
-463927000
Annuals > 0 > income Statement > eps
-3.8027629912086285
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
121997348
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-448082000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
105619000
Annuals > 0 > balance Sheet > cash
387878000
Annuals > 0 > balance Sheet > short Term Investments
1359330000
Annuals > 0 > balance Sheet > receivables
20662000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1787985000
Annuals > 0 > balance Sheet > property Plant Equipment
270147000
Annuals > 0 > balance Sheet > total Assets
3511318000
Annuals > 0 > balance Sheet > payables
48452000
Annuals > 0 > balance Sheet > short Term Debt
5891000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
205499000
Annuals > 0 > balance Sheet > equity
3305819000
Annuals > 0 > cash Flow > net Income
-463927000
Annuals > 0 > cash Flow > depreciation
15845000
Annuals > 0 > cash Flow > change In Working Capital
-54895000
Annuals > 0 > cash Flow > cash From Operations
-452627000
Annuals > 0 > cash Flow > capital Expenditures
22427000
Annuals > 0 > cash Flow > cash From Investing
-2005666000
Annuals > 0 > cash Flow > cash From Financing
2448508000
Annuals > 0 > cash Flow > net Change In Cash
-9359000
Annuals > 0 > ratios > PE
-3.8027629912086285
Annuals > 0 > ratios > PB
1.6496007360354574
Annuals > 0 > ratios > ROE
-14.033647940192735
Annuals > 0 > ratios > ROA
-13.212332235360055
Annuals > 0 > ratios > FCF
-475054000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
75000000
Annuals > 1 > income Statement > gross Profit
-75000000
Annuals > 1 > income Statement > operating Expenses
468041000
Annuals > 1 > income Statement > operating Income
-468041000
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-402266000
Annuals > 1 > income Statement > net Income
-402266000
Annuals > 1 > income Statement > eps
-4.1403413358222085
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
97157690
Annuals > 1 > income Statement > income Tax Expense
-402266000
Annuals > 1 > income Statement > EBITDA
-392095000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
65775000
Annuals > 1 > balance Sheet > cash
397451000
Annuals > 1 > balance Sheet > short Term Investments
682776000
Annuals > 1 > balance Sheet > receivables
3607000
Annuals > 1 > balance Sheet > inventories
-6159000
Annuals > 1 > balance Sheet > total Current Assets
1095954000
Annuals > 1 > balance Sheet > property Plant Equipment
110623000
Annuals > 1 > balance Sheet > total Assets
1407917000
Annuals > 1 > balance Sheet > payables
14587000
Annuals > 1 > balance Sheet > short Term Debt
7113000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
167449000
Annuals > 1 > balance Sheet > equity
1240468000
Annuals > 1 > cash Flow > net Income
-402266000
Annuals > 1 > cash Flow > depreciation
10171000
Annuals > 1 > cash Flow > change In Working Capital
81320000
Annuals > 1 > cash Flow > cash From Operations
-296790000
Annuals > 1 > cash Flow > capital Expenditures
67877000
Annuals > 1 > cash Flow > cash From Investing
-773311000
Annuals > 1 > cash Flow > cash From Financing
639813000
Annuals > 1 > cash Flow > net Change In Cash
-436974000
Annuals > 1 > ratios > PE
-4.1403413358222085
Annuals > 1 > ratios > PB
3.5010566520055333
Annuals > 1 > ratios > ROE
-32.428567282670734
Annuals > 1 > ratios > ROA
-28.571712679085486
Annuals > 1 > ratios > FCF
-364667000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
9196000
Annuals > 2 > income Statement > gross Profit
-9196000
Annuals > 2 > income Statement > operating Expenses
232256000
Annuals > 2 > income Statement > operating Income
-232256000
Annuals > 2 > income Statement > interest Expense
2000
Annuals > 2 > income Statement > pretax Income
-223485000
Annuals > 2 > income Statement > net Income
-223485000
Annuals > 2 > income Statement > eps
-3.444696836159592
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
64877988
Annuals > 2 > income Statement > income Tax Expense
16155000
Annuals > 2 > income Statement > EBITDA
-214030000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
8771000
Annuals > 2 > balance Sheet > cash
834657000
Annuals > 2 > balance Sheet > short Term Investments
96719000
Annuals > 2 > balance Sheet > receivables
1000000
Annuals > 2 > balance Sheet > inventories
-1000000
Annuals > 2 > balance Sheet > total Current Assets
942555000
Annuals > 2 > balance Sheet > property Plant Equipment
31648000
Annuals > 2 > balance Sheet > total Assets
1006178000
Annuals > 2 > balance Sheet > payables
9795000
Annuals > 2 > balance Sheet > short Term Debt
5910000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
52565000
Annuals > 2 > balance Sheet > equity
953613000
Annuals > 2 > cash Flow > net Income
-223485000
Annuals > 2 > cash Flow > depreciation
9453000
Annuals > 2 > cash Flow > change In Working Capital
12737000
Annuals > 2 > cash Flow > cash From Operations
-170597000
Annuals > 2 > cash Flow > capital Expenditures
5841000
Annuals > 2 > cash Flow > cash From Investing
74585000
Annuals > 2 > cash Flow > cash From Financing
861547000
Annuals > 2 > cash Flow > net Change In Cash
765672000
Annuals > 2 > ratios > PE
-3.444696836159592
Annuals > 2 > ratios > PB
3.0411142293571922
Annuals > 2 > ratios > ROE
-23.435607526323572
Annuals > 2 > ratios > ROA
-22.211278720067423
Annuals > 2 > ratios > FCF
-176438000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
29
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1800000
Annuals > 3 > income Statement > gross Profit
-1800000
Annuals > 3 > income Statement > operating Expenses
103670000
Annuals > 3 > income Statement > operating Income
-103670000
Annuals > 3 > income Statement > interest Expense
7000
Annuals > 3 > income Statement > pretax Income
-100077000
Annuals > 3 > income Statement > net Income
-100077000
Annuals > 3 > income Statement > eps
-1.927444856437647
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
51922108
Annuals > 3 > income Statement > income Tax Expense
7000
Annuals > 3 > income Statement > EBITDA
-96613000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
3593000
Annuals > 3 > balance Sheet > cash
68985000
Annuals > 3 > balance Sheet > short Term Investments
176985000
Annuals > 3 > balance Sheet > receivables
1200000
Annuals > 3 > balance Sheet > inventories
-1200000
Annuals > 3 > balance Sheet > total Current Assets
256348000
Annuals > 3 > balance Sheet > property Plant Equipment
35912000
Annuals > 3 > balance Sheet > total Assets
324337000
Annuals > 3 > balance Sheet > payables
6758000
Annuals > 3 > balance Sheet > short Term Debt
5276000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
40319000
Annuals > 3 > balance Sheet > equity
284018000
Annuals > 3 > cash Flow > net Income
-100077000
Annuals > 3 > cash Flow > depreciation
3457000
Annuals > 3 > cash Flow > change In Working Capital
-37005000
Annuals > 3 > cash Flow > cash From Operations
-121393000
Annuals > 3 > cash Flow > capital Expenditures
6555000
Annuals > 3 > cash Flow > cash From Investing
-212308000
Annuals > 3 > cash Flow > cash From Financing
17796000
Annuals > 3 > cash Flow > net Change In Cash
-316344000
Annuals > 3 > ratios > PE
-1.927444856437647
Annuals > 3 > ratios > PB
8.171729353773353
Annuals > 3 > ratios > ROE
-35.236147004767304
Annuals > 3 > ratios > ROA
-30.85586904978464
Annuals > 3 > ratios > FCF
-127948000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
27
Valuation > metrics > PE
-1.5626743810390906
Valuation > metrics > PB
2.0950463931816095
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-7.357023203850001
Profitability > metrics > ROA
-12.043570302071055
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.09634613509987618
Risk > metrics > Interest Coverage
-79.10574412532637
Risk > final Score
-256
Risk > verdict
High
Liquidity > metrics > Current Ratio
32.28704803317925
Liquidity > metrics > Quick Ratio
32.28704803317925
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-121
Prev Risks > 1
39
Prev Risks > 2
52
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:00:18.120Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-02
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-1.47
Earnings History > 0 > eps Difference
1.47
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-04
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.56
Earnings History > 1 > eps Estimate
-1.24
Earnings History > 1 > eps Difference
-0.32
Earnings History > 1 > surprise Percent
-25.8065
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-06
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.22
Earnings History > 2 > eps Estimate
-1.17
Earnings History > 2 > eps Difference
-0.05
Earnings History > 2 > surprise Percent
-4.2735
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-1.04
Earnings History > 3 > eps Estimate
-0.975
Earnings History > 3 > eps Difference
-0.065
Earnings History > 3 > surprise Percent
-6.6667
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-25
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.0176
Earnings History > 4 > eps Estimate
-0.992
Earnings History > 4 > eps Difference
-0.0256
Earnings History > 4 > surprise Percent
-2.5806
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-04
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.83
Earnings History > 5 > eps Estimate
-1.13
Earnings History > 5 > eps Difference
0.3
Earnings History > 5 > surprise Percent
26.5487
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-06
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.1
Earnings History > 6 > eps Estimate
-0.98
Earnings History > 6 > eps Difference
-0.12
Earnings History > 6 > surprise Percent
-12.2449
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-08
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.85
Earnings History > 7 > eps Estimate
-1.17
Earnings History > 7 > eps Difference
0.32
Earnings History > 7 > surprise Percent
27.3504
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-27
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.82
Earnings History > 8 > eps Estimate
-1.07
Earnings History > 8 > eps Difference
-0.75
Earnings History > 8 > surprise Percent
-70.0935
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-06
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.91
Earnings History > 9 > eps Estimate
-0.84
Earnings History > 9 > eps Difference
-0.07
Earnings History > 9 > surprise Percent
-8.3333
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-08
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.7
Earnings History > 10 > eps Estimate
-0.74
Earnings History > 10 > eps Difference
0.04
Earnings History > 10 > surprise Percent
5.4054
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-08
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.7
Earnings History > 11 > eps Estimate
-0.83
Earnings History > 11 > eps Difference
0.13
Earnings History > 11 > surprise Percent
15.6627
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-27
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-1.02
Earnings History > 12 > eps Estimate
-0.93
Earnings History > 12 > eps Difference
-0.09
Earnings History > 12 > surprise Percent
-9.6774
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-07
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.93
Earnings History > 13 > eps Estimate
-0.84
Earnings History > 13 > eps Difference
-0.09
Earnings History > 13 > surprise Percent
-10.7143
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-08
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.8
Earnings History > 14 > eps Estimate
-0.69
Earnings History > 14 > eps Difference
-0.11
Earnings History > 14 > surprise Percent
-15.942
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-09
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.68
Earnings History > 15 > eps Estimate
-0.63
Earnings History > 15 > eps Difference
-0.05
Earnings History > 15 > surprise Percent
-7.9365
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-28
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.55
Earnings History > 16 > eps Estimate
-0.56
Earnings History > 16 > eps Difference
0.01
Earnings History > 16 > surprise Percent
1.7857
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.51
Earnings History > 17 > eps Estimate
-0.55
Earnings History > 17 > eps Difference
0.04
Earnings History > 17 > surprise Percent
7.2727
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-11
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.46
Earnings History > 18 > eps Estimate
-0.52
Earnings History > 18 > eps Difference
0.06
Earnings History > 18 > surprise Percent
11.5385
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-11
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.41
Earnings History > 19 > eps Estimate
-0.48
Earnings History > 19 > eps Difference
0.07
Earnings History > 19 > surprise Percent
14.5833
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-29
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.41
Earnings History > 20 > eps Estimate
-0.54
Earnings History > 20 > eps Difference
0.13
Earnings History > 20 > surprise Percent
24.0741
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-12
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.41
Earnings History > 21 > eps Estimate
-0.44
Earnings History > 21 > eps Difference
0.03
Earnings History > 21 > surprise Percent
6.8182
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-12
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-1.72
Earnings History > 22 > eps Estimate
-1.27
Earnings History > 22 > eps Difference
-0.45
Earnings History > 22 > surprise Percent
-35.4331
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-06-15
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.29
Earnings History > 23 > eps Estimate
-4.88
Earnings History > 23 > eps Difference
4.59
Earnings History > 23 > surprise Percent
94.0574
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-13
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-1.08
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-1.08
Earnings History > 24 > surprise Percent
-
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; and VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHow Vaxcyte’s Phase 3 Head-to-Head VAX-31 Trial Could Shape Vaxcyte (PCVX) Investors - Yahoo Finance
12/14/2025
How Vaxcyte’s Phase 3 Head-to-Head VAX-31 Trial Could Shape Vaxcyte (PCVX) Investors Yahoo Finance
Read more →Vaxcyte (PCVX): Assessing a Discounted Valuation After a Volatile Year in the Share Price Yahoo Finance
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$92
Analyst Picks
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Medium
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 115.08% of the total shares of Vaxcyte Inc
1.
HHG PLC(11.3164%)
since
2025/06/30
2.
FMR Inc(9.3597%)
since
2025/06/30
3.
Vanguard Group Inc(9.2411%)
since
2025/06/30
4.
RA Capital Management, LLC(9.2171%)
since
2025/06/30
5.
BlackRock Inc(8.1975%)
since
2025/06/30
6.
T. Rowe Price Investment Management,Inc.(4.6225%)
since
2025/06/30
7.
Wellington Management Company LLP(3.8166%)
since
2025/06/30
8.
State Street Corp(3.8069%)
since
2025/06/30
9.
Capital Research Global Investors(3.6756%)
since
2025/06/30
10.
Vanguard Total Stock Mkt Idx Inv(2.972%)
since
2025/07/31
11.
Paradigm Biocapital Advisors LP(2.598%)
since
2025/06/30
12.
T. Rowe Price Associates, Inc.(2.442%)
since
2025/06/30
13.
D. E. Shaw & Co LP(2.379%)
since
2025/06/30
14.
Kynam Capital Management, LP(2.366%)
since
2025/06/30
15.
Westfield Capital Management Company, L.P.(2.3639%)
since
2025/06/30
16.
iShares Russell 2000 ETF(2.3299%)
since
2025/08/31
17.
Geode Capital Management, LLC(2.3194%)
since
2025/06/30
18.
Vanguard Small Cap Index(2.2922%)
since
2025/07/31
19.
Vanguard Health Care Inv(2.183%)
since
2025/06/30
20.
Janus Henderson Enterprise D(2.0355%)
since
2025/06/30
21.
Janus Inst Mid Cap Growth CF(2.0355%)
since
2025/06/30
22.
Janus Concentrated Growth CF(1.6608%)
since
2025/06/30
23.
Janus Henderson Forty S(1.6608%)
since
2025/06/30
24.
Deep Track Capital, LP(1.6561%)
since
2025/06/30
25.
SPDR® S&P Biotech ETF(1.5496%)
since
2025/08/31
26.
T. Rowe Price Mid-Cap Growth(1.3455%)
since
2025/07/31
27.
American Funds New Economy A(1.3372%)
since
2025/06/30
28.
Capital Group New Economy Comp(1.3372%)
since
2025/06/30
29.
Vanguard Small Cap Growth Index Inv(1.2791%)
since
2025/07/31
30.
T. Rowe Price US Mid-Cap Growth Equity(1.2324%)
since
2025/06/30
31.
Fidelity Advisor Growth Opps M(1.2046%)
since
2025/07/31
32.
American Funds SMALLCAP World A(1.1466%)
since
2025/06/30
33.
Charles Schwab Investment Management Inc(1.092%)
since
2025/06/30
34.
Jennison Associates LLC(1.0778%)
since
2025/06/30
35.
UBS Group AG(1.0636%)
since
2025/06/30
36.
Maverick Capital Ltd(1.0095%)
since
2025/06/30
37.
Vanguard Institutional Extnd Mkt Idx Tr(0.9818%)
since
2025/07/31
38.
Fidelity Small Cap Index(0.9726%)
since
2025/06/30
39.
American Funds Growth Fund of Amer A(0.9513%)
since
2025/06/30
40.
Capital Group Growth Fnd of Amer Comp(0.9513%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-1.47
Date
2025-09-30
EPS Actual
-1.56
EPS Estimate
-1.24
EPS Difference
-0.32
Surprise Percent
-25.8065%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.